NEW YORK RENAL PHYSICIANS IPA, LLC
NPI 1831430990
Clinic/Center - End-Stage Renal Disease (ESRD) Treatment in Ridgewood, NY
NPI Status: Active since March 13, 2013
Contact Information
385 SENECA AVE
RIDGEWOOD, NY
ZIP 11385
Phone: (718) 483-7428
- Organization
- Clinic/Center
- End-Stage Renal Disease (ESRD) Treatment
About NEW YORK RENAL PHYSICIANS IPA, LLC
This page provides the complete NPI Profile along with additional information for New York Renal Physicians Ipa, Llc, a provider established in Ridgewood, New York operating as a Clinic/center, focusing in end-stage renal disease (esrd) treatment . The healthcare provider is registered in the NPI registry with number 1831430990 assigned on March 2013. The practitioner's primary taxonomy code is 261QE0700X. The provider is registered as an organization and their NPI record was last updated 13 years ago. The authorized official of this NPI record is Jodumutt Ganesh Bhat Md (Co-principal)
- NPI
- 1831430990
- Provider Name
- NEW YORK RENAL PHYSICIANS IPA, LLC
- Entity Type
- Organization
- Location Address
- 385 SENECA AVE RIDGEWOOD, NY 11385
- Location Phone
- (718) 483-7428
- Mailing Address
- 385 SENECA AVE RIDGEWOOD, NY 11385
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 03-13-2013
- Last Update Date
- 03-13-2013
- Code Navigator
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinic/Center End-Stage Renal Disease (ESRD) Treatment
- Taxonomy Code
- 261QE0700X
- Type
- Ambulatory Health Care Facilities
- License State
- NY
Reviews for NEW YORK RENAL PHYSICIANS IPA, LLC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1831430990, we treat the final digit (0) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 70. The final step is to find the difference between that total and the next multiple of ten (70 - 70 = 0).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 70 is 70. The difference is the calculated check digit.
Other Providers at the Same Location
The following 13 providers are registered at the same or a nearby location.
RIDGEWOOD, NY 11385
RIDGEWOOD, NY 11385
RIDGEWOOD, NY 11385
RIDGEWOOD, NY 11385
RIDGEWOOD, NY 11385
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1831430990, enumerated as an "organization" on March 13, 2013.
The provider is located at 385 SENECA AVE RIDGEWOOD, NY 11385 and the phone number is (718) 483-7428.
Clinic/Center with taxonomy code 261QE0700X and a focus in End-Stage Renal Disease (ESRD) Treatment.
